A prospective study of Parkinson’s disease dementia – defining neuropsychological features
Objective: To identify neuropsychological predictors of conversion to dementia (PDD) in our cohort of Parkinson’s disease (PD) patients. Background: The heterogeneity of PD cognitive disorders…Cognitive function and quality of life in Parkinson’s disease: A cross-sectional study
Objective: We aimed to determine how the cognitive domains affect quality of life (QoL) in different cognitive states in PD. Background: Parkinson’s disease with mild…Predictors of transfer to facility or nursing home after discharge of inpatients with Parkinson’s disease: A Japanese single center retrospective study
Objective: To investigate the reasons for hospital admissions for Parkinson's disease (PD) patients and to determine the predictors of transfer to facility or nursing home…Serum microRNA-29 family as potential biomarkers for cognitive impairment in Parkinson’s disease
Objective: To examine whether miRNA-29s (miR-29s) in serum could be used as biomarkers for either Parkinson’s disease with dementia (PDD) or Parkinson’s disease with mild…Quantitative method for designing appropriate longitudinal follow-up frequency with application to Parkinson’s disease cognition research
Objective: To develop a quantitative method for designing appropriate longitudinal follow-up frequency. We demonstrate how to use this new method using a progression study of…Vascular, inflammatory and metabolic risk factors in relation to dementia in Parkinson’s disease patients with type 2 diabetes mellitus
Objective: Identifying the risk factors of dementia in patients with both Parkinson’s disease (PD) and type 2 diabetes mellitus (DM) (PD-DM) is clinically relevant and…Prion disease with 8 octapeptide repeat insertional mutation presenting with HDL1 phenotype
Objective: To report the clinical and genetic features in a patient with an insertion of 8 extra octapeptide repeats in the prion protein gene (PRNP).…Candidate plasma miRNAs and EV protein as novel biomarkers in Parkinson’s disease patients with cognitive impairment and dementia
Objective: To determine the diagnostic value of circulating miRNAs and the extracellular vesicle proteins for early detection of patients with Parkinson’s disease and mild cognitive…First Scientific Description of the Hepato-Lenticular Degeneration
Objective: Hepato-Lenticular Degeneration (HLD) first described by German pathologist Friedrich Theodor von Frerichs in 1854, but in the West it called Wilson's Disease. In Russia…Identification and clinical characteristics of Mild Cognitive Impairment in Parkinson’s disease
Objective: To examine the characteristics of mild cognitive impairment in Parkinson’s disease (PD) patients with mild cognitive impairment (MCI) Background: Cognitive disturbances in PD detrimentally…
- « Previous Page
- 1
- …
- 9
- 10
- 11
- 12
- 13
- …
- 33
- Next Page »